Medpace Holdings
Medpace Holdings Inc is a global contract research organization headquartered in Cincinnati, Ohio. The company provides full-service clinical development services to the biotechnology, pharmaceutical, and medical device industries. Its service offerings cover clinical trial management, medical writing, regulatory affairs, central laboratory operations, and biostatistics across phases one to four. Principal revenue is derived from fee-for-service contracts to execute clinical trials on behalf of sponsor companies. The firm focuses primarily on small to mid-sized biopharmaceutical enterprises across oncology, cardiology, metabolic, and infectious disease therapeutic areas. Medpace Holdings Inc is listed on the Nasdaq stock exchange.
24 of the funds FundTelligence covers report a position in Medpace Holdings.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 24
Funds holding Medpace Holdings
- PriorNilsson Evolve Global — PriorNilsson · 5.4 % (full portfolio disclosed, June 2026)
- Carnegie US Small & Micro Cap — Carnegie · 2.95 % (full portfolio disclosed, June 2026)
- Carnegie Global Resilient Small Cap — Carnegie · 2.88 % (full portfolio disclosed, June 2026)
- Nordea Global Social Empowerment — Nordea Funds · 1.94 % (full portfolio disclosed, September 2026)
- Nordea Fremtid — Nordea Funds · 1.75 % (full portfolio disclosed, September 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 1.52 % (full portfolio disclosed, October 2026)
- Nordea Global Small Cap Enhanced — Nordea Funds · 1.5 % (full portfolio disclosed, September 2026)
- Nordea Global Small Cap — Nordea Funds · 1.49 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 24 funds holding it.